Reiko Inagi
- Molecular Biology top 2%
- Nephrology top 0.1%
- Clinical Biochemistry top 0.05%
- Physiology top 1%
- Epidemiology top 2%
- Co-authors
- Masaomi NangakuToshio MiyataToshiro FujitaTetsuhiro TanakaKiyoshi KurokawaYu IshimotoHiroshi NishiHiroshi Maekawa
- Topics
- Advanced Glycation End Products research (39 papers)Chronic Kidney Disease and Diabetes (31 papers)Endoplasmic Reticulum Stress and Disease (21 papers)
- Partner nations
- JapanUnited StatesBelgium
In The Last Decade
Reiko Inagi
192 papers receiving 9.9k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Molecular Biology 2.9k
- Nephrology 2.7k
- Clinical Biochemistry 2.1k
- Physiology 1.4k
- Epidemiology 1.4k
Countries citing papers authored by Reiko Inagi
This map shows the geographic impact of Reiko Inagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reiko Inagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reiko Inagi more than expected).
Fields of papers citing papers by Reiko Inagi
This network shows the impact of papers produced by Reiko Inagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reiko Inagi. The network helps show where Reiko Inagi may publish in the future.
Co-authorship network of co-authors of Reiko Inagi
This figure shows the co-authorship network connecting the top 25 collaborators of Reiko Inagi. A scholar is included among the top collaborators of Reiko Inagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reiko Inagi. Reiko Inagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 13 | |
| 4 | 68 | |
| 5 | 5 | |
| 6 | 9 | |
| 7 | 38 | |
| 8 | 44 | |
| 9 | 111 | |
| 10 | 9 | |
| 11 | 32 | |
| 12 | 12 | |
| 13 | 86 | |
| 14 | 2 | |
| 15 | 24 | |
| 16 | 36 | |
| 17 | 3 | |
| 18 | 255 | |
| 19 | 120 | |
| 20 | 348 |
About Reiko Inagi
Reiko Inagi is a scholar working on Nephrology, Clinical Biochemistry and Cell Biology, having authored 194 papers that have together received 10.1k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (39 papers), Chronic Kidney Disease and Diabetes (31 papers) and Endoplasmic Reticulum Stress and Disease (21 papers). The work is most often cited by research in Nephrology (2.7k citations), Clinical Biochemistry (2.1k citations) and Biochemistry (555 citations). Reiko Inagi has collaborated with scholars based in Japan, United States and Belgium. Frequent co-authors include Masaomi Nangaku, Toshio Miyata, Toshiro Fujita, Tetsuhiro Tanaka, Kiyoshi Kurokawa, Yu Ishimoto, Hiroshi Nishi, Hiroshi Maekawa, Charles van Ypersele de Strihou and Takamoto Ohse. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.